Tin tức & Cập nhật

Pharmacist-led collaborative gout clinic helps patients achieve serum uric acid goals
Pharmacist-led collaborative gout clinic helps patients achieve serum uric acid goals
06 Feb 2023 bởiStephen Padilla

A collaborative clinic led by a pharmacist helps patients with gout to attain better clinical outcomes in the management of their condition, even in the presence of renal impairment, reports a Singapore study. The clinic provides safe, stepwise increments of urate-lowering therapy (ULT) in addition to serum uric acid (SUA) monitoring and adherence reinforcement through frequent initial visits.

Pharmacist-led collaborative gout clinic helps patients achieve serum uric acid goals
06 Feb 2023
Pain, discomfort persist in JIA patients despite medication use
Pain, discomfort persist in JIA patients despite medication use
18 Jan 2023
Can RA patients taper MTX from targeted therapy?
Can RA patients taper MTX from targeted therapy?
18 Jan 2023
CVD, mood disorders up risk of dementia in RA patients
CVD, mood disorders up risk of dementia in RA patients
17 Jan 2023 bởiStephen Padilla

Among patients with rheumatoid arthritis (RA), those with clinically active RA, cardiovascular or cerebrovascular disease (CVD), hypertension, depression, and anxiety are at greater risk of dementia, reveals a study. Among CVD events, ischaemic stroke and heart failure are significantly associated with an increased dementia risk.

CVD, mood disorders up risk of dementia in RA patients
17 Jan 2023
Etanercept biosimilar demonstrates long-term safety, efficacy in rheumatoid arthritis
Etanercept biosimilar demonstrates long-term safety, efficacy in rheumatoid arthritis
14 Jan 2023

YLB113, a biosimilar of the reference product etanercept, appears to be safe for long-term treatment of patients with rheumatoid arthritis, with efficacy sustained for up to 96 weeks, according to a study. Notably, the biosimilar is associated with fewer cases of injection-site reactions and injection-site erythema compared with the reference.

Etanercept biosimilar demonstrates long-term safety, efficacy in rheumatoid arthritis
14 Jan 2023